BlueRock Therapeutics LP

In News

BlueRock Therapeutics advances investigational cell therapy bemdaneprocel for treating Parkinson’s disease to registrational Phase III clinical trial - Bayer

Bayer - Jan 13, 2025

Bayer: testing OpCT-001, an experimental cell therapy - MarketScreener

MarketScreener - Jul 08, 2025

BlueRock Therapeutics announces publication in Nature of 18-month data from Phase 1 clinical trial for bemdaneprocel, an investigational cell therapy for Parkinson’s disease - GlobeNewswire

GlobeNewswire - Apr 16, 2025

BlueRock accelerates Parkinson’s disease therapy to Phase III - Clinical Trials Arena

Clinical Trials Arena - Jan 14, 2025

FDA grants IND clearance for BlueRock's primary photoreceptor disease cell therapy - Eyes On Eyecare

Eyes On Eyecare - Sep 04, 2024

BlueRock Receive FDA clearance of IND for Investigational iPSC-derived Cell Therapy OpCT-001 - BioInformant

BioInformant - Sep 09, 2024

BlueRock Therapeutics’ investigational cell therapy bemdaneprocel for Parkinson’s disease shows positive data at 24-months - Bayer

Bayer - Sep 27, 2024

Bayer-BlueRock Therapeutics bags USFDA Fast Track Designation for primary photoreceptor diseases... - Medical Dialogues

Medical Dialogues - Mar 03, 2025

Stem Cell Therapy Market Types, Applications, Share, Growth - openPR.com

openPR.com - Feb 05, 2025

CCRM: Building A Global Regenerative Medicine Ecosystem From Canadian Roots - insights.citeline.com

insights.citeline.com - Feb 11, 2025

BlueRock Therapeutics Assessing the Potential of Cell Therapy for Parkinson Disease With Phase 1 Trial for Bemdaneprocel - CGTLive®

CGTLive® - Jul 22, 2024

BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial - PR Newswire

PR Newswire - Mar 14, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.